Page last updated: 2024-11-04

sulforaphane and Fra(X) Syndrome

sulforaphane has been researched along with Fra(X) Syndrome in 1 studies

sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Napoli, E1
Flores, A1
Mansuri, Y1
Hagerman, RJ1
Giulivi, C1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Open-Label Trial of Sulforaphane in Premutation Carriers With FXTAS to Find Biomarkers[NCT05233579]15 participants (Actual)Interventional2021-06-25Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for sulforaphane and Fra(X) Syndrome

ArticleYear
Sulforaphane improves mitochondrial metabolism in fibroblasts from patients with fragile X-associated tremor and ataxia syndrome.
    Neurobiology of disease, 2021, Volume: 157

    Topics: Aged; Aged, 80 and over; Ataxia; Energy Metabolism; Female; Fibroblasts; Fragile X Syndrome; Humans;

2021